Does the media prefer SI or COIN?

In the previous week, Coinbase Global had 51 more articles in the media than Shoulder Innovations. MarketBeat recorded 57 mentions for Coinbase Global and 6 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.63 beat Shoulder Innovations' score of 0.48 indicating that Coinbase Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Coinbase Global 25 Very Positive mention(s) 10 Positive mention(s) 10 Neutral mention(s) 6 Negative mention(s) 5 Very Negative mention(s) Positive

Does the media favor SI or ATEC?

In the previous week, Shoulder Innovations had 3 more articles in the media than Alphatec. MarketBeat recorded 6 mentions for Shoulder Innovations and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.47 beat Shoulder Innovations' score of 0.48 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alphatec 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CNMD or SI?

In the previous week, Shoulder Innovations had 3 more articles in the media than CONMED. MarketBeat recorded 6 mentions for Shoulder Innovations and 3 mentions for CONMED. CONMED's average media sentiment score of 0.60 beat Shoulder Innovations' score of 0.48 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shoulder Innovations 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ENOV or SI?

In the previous week, Enovis had 6 more articles in the media than Shoulder Innovations. MarketBeat recorded 12 mentions for Enovis and 6 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.48 beat Enovis' score of 0.45 indicating that Shoulder Innovations is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NNNN or SI?

Shoulder Innovations has a consensus target price of $23.50, indicating a potential upside of 6.09%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts clearly believe Shoulder Innovations is more favorable than Anbio Biotechnology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anbio Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shoulder Innovations 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.63

Which has higher earnings & valuation, NNNN or SI?

Anbio Biotechnology has higher earnings, but lower revenue than Shoulder Innovations. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Anbio Biotechnology $8.65M 113.28 $6.40M N/A N/A Shoulder Innovations $47.32M 9.75 -$40.36M -$1.92 N/A

Does the media prefer NNNN or SI?

In the previous week, Shoulder Innovations had 3 more articles in the media than Anbio Biotechnology. MarketBeat recorded 6 mentions for Shoulder Innovations and 3 mentions for Anbio Biotechnology. Shoulder Innovations' average media sentiment score of 0.48 beat Anbio Biotechnology's score of 0.04 indicating that Shoulder Innovations is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anbio Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Shoulder Innovations (SI) Competitors

$22.15 +0.05 (+0.23%)

As of 08/21/2026 03:58 PM Eastern

Compare

SI vs. COIN, ATEC, CNMD, ENOV, and NNNN

Should you buy Shoulder Innovations stock or one of its competitors? Shoulder Innovations's main competitors and comparable companies include Coinbase Global (COIN), Alphatec (ATEC), CONMED (CNMD), Enovis (ENOV), and Anbio Biotechnology (NNNN). Companies are selected based on similarities in market, industry, and size.

How does Shoulder Innovations compare to Coinbase Global?

Shoulder Innovations (NYSE:SI) and Coinbase Global (NASDAQ:COIN) are related companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Coinbase Global has higher revenue and earnings than Shoulder Innovations. Coinbase Global is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	9.75	-$40.36M	-$1.92	N/A
Coinbase Global	$7.18B	6.85	$1.26B	-$3.84	N/A

In the previous week, Coinbase Global had 51 more articles in the media than Shoulder Innovations. MarketBeat recorded 57 mentions for Coinbase Global and 6 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.63 beat Shoulder Innovations' score of 0.48 indicating that Coinbase Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Coinbase Global	25 Very Positive mention(s)	10 Positive mention(s)	10 Neutral mention(s)	6 Negative mention(s)	5 Very Negative mention(s)	Positive

68.8% of Coinbase Global shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 16.7% of Coinbase Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Shoulder Innovations presently has a consensus target price of $23.50, suggesting a potential upside of 6.09%. Coinbase Global has a consensus target price of $215.11, suggesting a potential upside of 15.35%. Given Coinbase Global's higher probable upside, analysts plainly believe Coinbase Global is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
Coinbase Global	5 Sell rating(s)	9 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.41

Coinbase Global has a net margin of -15.72% compared to Shoulder Innovations' net margin of -58.33%. Coinbase Global's return on equity of 3.12% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Coinbase Global	-15.72%	3.12%	1.54%

Summary

Coinbase Global beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to Alphatec?

Shoulder Innovations (NYSE:SI) and Alphatec (NASDAQ:ATEC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

In the previous week, Shoulder Innovations had 3 more articles in the media than Alphatec. MarketBeat recorded 6 mentions for Shoulder Innovations and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.47 beat Shoulder Innovations' score of 0.48 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alphatec	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

66.4% of Alphatec shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 13.5% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Alphatec has a net margin of -13.49% compared to Shoulder Innovations' net margin of -58.33%. Shoulder Innovations' return on equity of -23.61% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Alphatec	-13.49%	-6,752.24%	-13.88%

Shoulder Innovations has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	9.75	-$40.36M	-$1.92	N/A
Alphatec	$764.16M	1.92	-$143.36M	-$0.71	N/A

Shoulder Innovations presently has a consensus price target of $23.50, indicating a potential upside of 6.09%. Alphatec has a consensus price target of $17.40, indicating a potential upside of 83.54%. Given Alphatec's stronger consensus rating and higher probable upside, analysts plainly believe Alphatec is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Alphatec beats Shoulder Innovations on 9 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to CONMED?

CONMED (NYSE:CNMD) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

CONMED has a net margin of 4.12% compared to Shoulder Innovations' net margin of -58.33%. CONMED's return on equity of 14.31% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

CONMED currently has a consensus target price of $41.40, indicating a potential downside of 19.25%. Shoulder Innovations has a consensus target price of $23.50, indicating a potential upside of 6.09%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts clearly believe Shoulder Innovations is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

CONMED has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.12	$47.06M	$1.85	27.71
Shoulder Innovations	$47.32M	9.75	-$40.36M	-$1.92	N/A

In the previous week, Shoulder Innovations had 3 more articles in the media than CONMED. MarketBeat recorded 6 mentions for Shoulder Innovations and 3 mentions for CONMED. CONMED's average media sentiment score of 0.60 beat Shoulder Innovations' score of 0.48 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CONMED beats Shoulder Innovations on 8 of the 13 factors compared between the two stocks.

How does Shoulder Innovations compare to Enovis?

Enovis (NYSE:ENOV) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

In the previous week, Enovis had 6 more articles in the media than Shoulder Innovations. MarketBeat recorded 12 mentions for Enovis and 6 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.48 beat Enovis' score of 0.45 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Enovis presently has a consensus price target of $41.29, indicating a potential upside of 57.46%. Shoulder Innovations has a consensus price target of $23.50, indicating a potential upside of 6.09%. Given Enovis' stronger consensus rating and higher possible upside, equities research analysts clearly believe Enovis is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

Enovis has a net margin of -47.96% compared to Shoulder Innovations' net margin of -58.33%. Enovis' return on equity of 12.03% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-47.96%	12.03%	4.91%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

98.5% of Enovis shares are held by institutional investors. 2.9% of Enovis shares are held by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Shoulder Innovations has lower revenue, but higher earnings than Enovis. Shoulder Innovations is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25B	0.67	-$1.18B	-$19.26	N/A
Shoulder Innovations	$47.32M	9.75	-$40.36M	-$1.92	N/A

Summary

Enovis beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to Anbio Biotechnology?

Anbio Biotechnology (NASDAQ:NNNN) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

In the previous week, Shoulder Innovations had 3 more articles in the media than Anbio Biotechnology. MarketBeat recorded 6 mentions for Shoulder Innovations and 3 mentions for Anbio Biotechnology. Shoulder Innovations' average media sentiment score of 0.48 beat Anbio Biotechnology's score of 0.04 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anbio Biotechnology	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Anbio Biotechnology has higher earnings, but lower revenue than Shoulder Innovations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anbio Biotechnology	$8.65M	113.28	$6.40M	N/A	N/A
Shoulder Innovations	$47.32M	9.75	-$40.36M	-$1.92	N/A

Anbio Biotechnology has a net margin of 0.00% compared to Shoulder Innovations' net margin of -58.33%. Anbio Biotechnology's return on equity of 0.00% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anbio Biotechnology	N/A	N/A	N/A
Shoulder Innovations	-58.33%	-23.61%	-19.53%

Shoulder Innovations has a consensus target price of $23.50, indicating a potential upside of 6.09%. Given Shoulder Innovations' stronger consensus rating and higher probable upside, analysts clearly believe Shoulder Innovations is more favorable than Anbio Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anbio Biotechnology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

Summary

Shoulder Innovations beats Anbio Biotechnology on 6 of the 11 factors compared between the two stocks.

Get Shoulder Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SI vs. The Competition

Export

Metric	Shoulder Innovations	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$459.27M	$6.02B	$7.37B	$24.30B
Dividend Yield	N/A	1.75%	2.53%	3.70%
P/E Ratio	-11.54	26.67	272.60	30.31
Price / Sales	9.75	45.38	618.96	19.89
Price / Cash	N/A	33.24	78.62	32.49
Price / Book	3.71	6.23	13.05	6.77
Net Income	-$40.36M	$150.07M	$3.47B	$1.07B
7 Day Performance	7.35%	0.69%	2.09%	-0.65%
1 Month Performance	9.55%	8.91%	6.64%	3.38%
1 Year Performance	75.38%	8.07%	25.02%	14.90%

Shoulder Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SI Shoulder Innovations	1.7448 of 5 stars	$22.15 +0.2%	$23.50 +6.1%	+75.4%	$459.27M	$47.32M	N/A	61	Insider Trade
COIN Coinbase Global	3.4986 of 5 stars	$148.47 -3.5%	$215.11 +44.9%	-41.7%	$40.60B	$7.18B	N/A	4,951	Trending News Options Volume Gap Up
ATEC Alphatec	3.5813 of 5 stars	$9.79 +0.4%	$17.40 +77.7%	-41.3%	$1.51B	$764.16M	N/A	700
CNMD CONMED	1.8743 of 5 stars	$50.42 +1.2%	$41.40 -17.9%	-8.2%	$1.49B	$1.37B	27.25	3,900	Positive News
ENOV Enovis	3.8232 of 5 stars	$26.08 +1.6%	$42.00 +61.0%	-16.5%	$1.48B	$2.25B	N/A	7,802	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SI) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shoulder Innovations (SI) Competitors

SI vs. COIN, ATEC, CNMD, ENOV, and NNNN

How does Shoulder Innovations compare to Coinbase Global?

Summary

How does Shoulder Innovations compare to Alphatec?

Summary

How does Shoulder Innovations compare to CONMED?

Summary

How does Shoulder Innovations compare to Enovis?

Summary

How does Shoulder Innovations compare to Anbio Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shoulder Innovations (SI) Competitors

SI vs. COIN, ATEC, CNMD, ENOV, and NNNN

How does Shoulder Innovations compare to Coinbase Global?

Which has better earnings & valuation, SI or COIN?

Does the media prefer SI or COIN?

Do institutionals and insiders believe in SI or COIN?

Do analysts rate SI or COIN?

Is SI or COIN more profitable?

Summary

How does Shoulder Innovations compare to Alphatec?

Does the media favor SI or ATEC?

Do insiders & institutionals have more ownership in SI or ATEC?

Is SI or ATEC more profitable?

Which has higher earnings and valuation, SI or ATEC?

Do analysts prefer SI or ATEC?

Summary

How does Shoulder Innovations compare to CONMED?

Is CNMD or SI more profitable?

Do analysts recommend CNMD or SI?

Which has stronger valuation & earnings, CNMD or SI?

Does the media prefer CNMD or SI?

Summary

How does Shoulder Innovations compare to Enovis?

Does the media prefer ENOV or SI?

Do analysts prefer ENOV or SI?

Is ENOV or SI more profitable?

Do institutionals & insiders have more ownership in ENOV or SI?

Which has stronger earnings & valuation, ENOV or SI?

Summary

How does Shoulder Innovations compare to Anbio Biotechnology?

Does the media prefer NNNN or SI?

Which has higher earnings & valuation, NNNN or SI?

Is NNNN or SI more profitable?

Do analysts recommend NNNN or SI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools